Skip to content
Toggle navigation
Home
About ALS
Toggle menu
What is ALS?
Causes and risk factors
Diagnosis
Symptoms
Speech problems
Breathing and swallowing
Pseudobulbar affect
Types of ALS
Familial ALS
Sporadic ALS
Living with ALS
Mental health
Diet
Exercise
Aids and adaptations
Treatments
Toggle menu
Approved treatments
Experimental treatments
Non-drug treatments
News
Columns
Toggle menu
Joyful Sorrow
— Kristin Neva
Living Well With ALS
— Dagmar Munn
OutSpoken
— James Clingman
Thunder Road
— Juliet Taylor
Archived columns
The Mighty Mind
— Rachel Doboga
In memoriam
Notes From the ALS Front
— Rick Jobus
ALS roadmap
Toggle menu
Multifaceted ALS treatment strategy
ALS facts vs. fiction
Early ALS intervention
Navigating complex treatment plans
Insurance and finances
Next steps after ALS diagnosis
ALS stages and progression
Forums
Advocacy partners
Search
Close drawer
What can we help you find today?
Search for:
Search
Search
Search for:
Search
Laura Flavell, PhD, —
Articles by Laura Flavell
Recent Posts
HEALEY ALS trial to allow longer follow-up, blood cell collection
As my caregiver duties increase, I need to let other things go
Neurosense finalizing protocol for Phase 3 trial of PrimeC for ALS
Medicare Advantage plans in US told to cover Qalsody for SOD1-ALS
Corcept’s dazucorilant fails to slow ALS progression in clinical trial
Envelope icon
Subscribe to our newsletter
Get regular updates to your inbox.
Your Email
Subscribe
Leave this field empty if you're human:
We use cookies
to enhance your experience on our website.
Privacy Policy
Accept
